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THE pROBLEM
Scientific evidence for various infectious agents as cause for psychosis in schizophrenia is not 
robust. Many pathogens that influence brain development might play a role in disease causation. 
It has been shown that influenza exposure before birth (1), exposure to herpes simplex during birth 
(2), or exposition to Toxoplasma gondii and other pathogens (3) increases risk for schizophrenia 
and/or compromises cognition. During psychosis, viral and also ancient retroviral elements 
become may activated in the brain (4, 5). The implication of this research for use in clinical practice 
is ambiguous, because a robust virus test is lacking. The current article explores the speculative, 
but testable hypothesis that HSV-1 a neurotropic virus infecting specific limbic brain regions is 
a necessary—but not sufficient—cause of psychosis in a significant proportion of schizophrenia 
patients. The test should qualify Koch’s adapted postulates for latent pathogens (6): It should be 
present in the affected organ only in diseased cases, it should explain the pathogenetic changes of 
the individual and last, the pathogen should be transmissible and carry a corresponding disease in 
an animal model. We chose to focus on HSV-1, which specifically infects limbic brain regions and 
explains neuropathological and behavioral deficits in acute psychotic, and further detioration in 
chronically schizophrenic patients, but may also accounts for extremely high (up to 60%) concord-
ance in monozygotic twins (7). HSV-1 is indeed abundantly present; up to 80% of adults harbor 
the virus and it is the only known virus, which has specific neurotropism for the limbic regions 
of the brain (8) involved in the inflammatory pathophysiology of schizophrenia (9). Transmitting 
the HSV in animals yields pathophysiological changes in the monoaminergic system mimicking 
aspects of the schizophrenia phenotype in humans (10). HSV is also omnipresent in evolutionary 
history of man (11). However, all these characteristics of the virus make it a candidate, may give 
a hint toward causation, or provide a little circumstantial evidence, but are by no means proof of 
causation.
THE HYpOTHESiS
Schizophrenia is a neurodevelopmental disease, with changes in the circuitry of the hippocampus 
shown postmortem, including a loss of lateralization in the dentate gyrus (12). The dentate gyrus 
is central to the cognitive adaptation of the human species across the life span, because this region 
is subject to adult neurogenesis, which secures life-long adaptation of memory to environmental 
influences, and neurogenesis is compromised in schizophrenia (13). The dentate gyrus is an primary 
target for HSV (14).
The virus hypothesis specified in this article is based on two remarkable phenomena, maybe 
combining to a third:
 1. It is remarkable how pluripotent stem cells within the subgranular zone divide under influence 
of epigenetic mechanisms that (temporarily) silence the neuronal phenotype in favor of the 
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stem cell phenotype, and how the suppression of neuronal 
phenotype is gradually relieved during differentiation into 
neurons (15). The master regulator of stemness and con-
secutive neuronal speciation is the transcription factor RE1 
silencing transcription factor (REST) (16). REST is highly 
expressed in the milieu of the stem cell niche, suppresses 
hundreds of genes that are neuron specific, and thereby forces 
the cells in a dedifferentiated state, to enable replication. The 
niche, in which these stem cells replicate and form primitive 
neuronal progenitors, is the subgranular zone, and further 
differentiation into neurons occurs while they move toward 
the granular zone. This process of gradual speciation into 
neurons is guided by growth factors such as BDNF and nerve 
growth factor (NGF), which gradually suppress the transcrip-
tion factor REST to enable neuronal genes to become more 
and more expressed on the way (17).
 2. It is remarkable how in transneuronal tracing experiments 
the large DNA virus HSV, travels easily from the afferents 
of a sensory neuron deeply into the brain, without creat-
ing a severe encephalitis and death (18). Neuronal tracing 
experiments, with HSV, or with the related virus pseudo rabies 
virus (PRV), witness this peculiarity of nature. HSV travels 
anterogradely (along the normal direction of conduction of 
electrical stimuli along the axon), from the oral cavity sensory 
axon of the trigeminal nerve (Nervus V) via the efferent of 
this nerve to the next neuronal soma in the trigeminal nucleus 
(medulla oblongata), sending an efferent to the soma in the 
dopaminergic nuclei in the midbrain (substantia nigra), 
sending again an efferent into the limbic brain. An animal 
model shows (part) of this potential route of infection (19). 
The presence of HSV DNA as observed in the brain of healthy 
controls (20) is remarkable, because no apparent destruction 
is found on the supposed ways of anterograde transport of the 
virus (8). The suppression of replication of viral DNA in the 
infected neuron relies heavily on REST. Dominance of REST 
silences promoters of genes essential for replication of HSV 
and thereby prevents reactivation of the virus in neurons (21).
 3. The remarkable hypothesis that might follow from the 
abovementioned is that stem cells in the dentate gyrus, which 
conserve stemness under influence of REST, contain very spe-
cific HSV gene elements that are forwarded into progenitors 
and thereby influence consecutive differentiation in a peculiar 
(schizophrenic) way: The necessary relief of REST to enable 
differentiation of the cell leads to partial derepression of the 
viral DNA element contained in the cell, which in combination 
with adverse life events (extreme social stress) is responsible 
for the neuroanatomical, neurophysiological, and behavioral 
phenotype of schizophrenia. The viral element present in stem 
cells, forwarded into progenitors, and partially expressed in 
differentiating cells, creates a certain variability on the differ-
entiation process, that is not necessarily detrimental, but also 
might give rise to exceptional creativity, when kept in check. 
To be kept in check, the differentiation needs to be guided by 
growth factors that have a dual role: (1) to keep the virus in a 
sufficiently suppressed state to prevent activation of the (viral) 
replication machinery and (2) to support the developing 
neuron and its afferents with sufficient force to differentiate 
(cholinergic) transmitter connectivity that is important for 
new cognitions. NGF is produced within the hippocampus 
(22), supports cholinergic input to the hippocampus (23), and 
suppresses HSV (24).
THE TEST
Some aspects of the hypothesis have been already proven in 
experiments: As mentioned above, in neuronal tracing experi-
ments have been shown how easy HSV (or PRV) reaches limbic 
regions of the brain and how this in line with the dopamine 
hypothesis of schizophrenia. The connectivity of substantia 
nigra with the dentate gyrus of the hippocampus supports the 
possibility of anterograde transport of the virus to the neuroge-
netic niche (25). In herpes simplex virus infected progenitors, 
or immortalized monoaminergic PC12 cells the virus is kept 
latent by NGF signaling (26), but NGF also forces the primitive 
cells into a neuronal differentiation program (27). The major 
weakness of the current virus hypothesis is that the exact nature 
of the viral elements that supposedly interfere with the differ-
entiation program in neuronal progenitors is not yet defined in 
detail. Many viral elements of HSV are kept latent by epigenetic 
silencing of promoters of these elements by REST. REST recruits 
histone deacetylases and lysine-specific demethylases (LSD) for 
suppression of gene transcription by epigenetic modification 
(28). When suppression by REST is relieved, which is observed 
during differentiation of the stem cell progenitor toward neu-
ronal speciation, the activation of viral genes would occur in 
a predictive manner as observed in the earliest phase in very 
delicate viral reactivation experiments: When immediate early 
genes of the virus become relieved from suppression by REST, the 
genes essential for DNA replication genes of the virus [thymidine 
kinase (TK) or ribonucleotide reductase] become transcribed 
(29, 30) An important candidate viral element present in human 
brain is the TK gene of HSV (31), The HSV-TK gene contains a 
promoter with a Sp1 responsive element (32), which is activated 
due to stress signals and plays an important role in reactivation 
of the virus (33) and is involved in schizophrenia (34). In our 
hypothesis, the HSV-TK gene element may become activated 
upon stress and thereby disrupt neuronal speciation in the hip-
pocampus and cause schizophrenia. For this specific hypothesis, 
all postulates of Koch regarding this specific viral gene/promoter 
have to apply. The viral element should be present in the stem cell 
niche of the patient, should interfere with neuronal speciation 
and integration of the neuron in the hippocampus under stress, 
and a similar pathophysiology has to apply when the viral element 
is introduced in the hippocampal stem cell niche in an animal 
model. These requirements could be fulfilled as follows: distract 
DNA from postmortem dentate gyrus brain material of schizo-
phrenia patients, assuming that the HSV-TK gene is still present 
as in postmortem cases of herpes encephalitis (31). Amplify the 
DNA sequence found in the autopsy material containing both 
the enhancer/promoter binding site and the gene of interest (in 
our case HSV-TK). If amplified DNA copies of this viral element 
are found (only) in patient brain tissue, this will satisfy the first 
postulate. Then introduce the viral element discovered in human 
brain tissue, by knock-in into human NSC (neuronal stem cells) 
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or PC12 cells that differentiate under control of NGF. Perform a 
detailed assessment of the phenotype of the differentiating cells 
with positive and negative control on the Sp1 stress response ele-
ments. If viral transduced neurons show a disrupted execution of 
the differentiation program and distrophical growth under Sp1 
stress, the second postulate is fulfilled in vitro. Then, genetically 
introducing the viral element into mice hippocampi should 
provide us with the proof of the final postulate of Koch, the fact 
that the viral element transmits disease in vivo. In these experi-
ments, the influence of the specific viral element discovered in 
human brain can be assessed regarding its influence on genesis, 
differentiation, migration and integration of neurons within 
the limbic network. To this aim, immunohistochemistry and 
fluorescent microscopy are very helpful, techniques that show us 
the normal neurogenetic mechanisms of cognition and what may 
go wrong (15).
THE CURE
Superficially, the cure for silencing of viral elements might 
seem easy: The only thing to do to keep the virus silent is sup-
press the transcription by silencing the promoter region of the 
viral element of interest epigenetically: keeping the activity of 
REST sufficiently high, as shown to be effective in viral knock-
in REST gene experiments, would suffice (21). However, in 
patients, this pharmacological way to improve suppression by 
REST needs stepping out of the usual antipsychotic therapy of 
schizophrenia. We would need trials with drugs that support the 
epigenetically silencing REST complex, such as the LSD inhibitor 
Tranylcypromine (35). Is it a coincidence that LSD inhibitors are 
by another mechanism—by mono amino-oxidase inhibition—
the most potent drugs to treat therapy resistant depression? 
Would suppression of viral elements by Tranylcypromine pro-
vide us with a cure for schizophrenia? Tranylcypromine might 
not only suppress expression of viral elements from HSV, but 
might also help to suppress other (retro)viral elements involved 
(4, 5). Suppressing the influence of stress on the expression of 
viral elements, might secure that neurogenesis is followed by 
proper differentiation of cell to neurons well integrated in the 
hippocampal circuitry and thereby prevent the accumulation of 
neurodevelopmental changes, found in postmortem hippocampi. 
It might basically cure schizophrenia by saving the patient from 
neurodevelopmental disarray. Medicinal treatment to prevent 
HSV replication might prove a far more effective treatment when 
compared with drugs that only limit HSV replication (36).
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